| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.25 | 0.4 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |